Intrigued by what Bell's team had published about GLP-1 she turned her attention to investigating the peptide (Molteni, Chen)
Common Side Effects Reported by Users Like other semaglutide medications, Hers compounded semaglutide comes with potential side effects
Commonly reported retatrutide side effects in trials include: Nausea (especially during dose increases) Vomiting Diarrhoea or constipation Abdominal pain or bloating Indigestion / reflux Injection-site reactions or hypersensitivity in some people So far, hair loss has not been listed as a common, direct side effect of retatrutide in clinical trial publications
FOR VOMITING SOURCE: MedlinePlus
Summary: Sulphur burps and diarrhoea are common gastrointestinal side effects of retatrutide, caused primarily by slowed gastric emptying and altered gut motility resulting from its triple receptor agonist activity
A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result
